Vendrov AE, Madamanchi N, Hakim ZS, Rojas M, Runge MS. Thrombin and NAD (P) H Oxidase-<ediated Regulation of CD44 and BMP4-Id Pathway in VSMC, Restenosis, and Artherosclerosis. Circulation Research. 2006; 98:1254-1263.

DiMichele LD, Doherty JT, Rojas M, Mack CP, Beggs HE, Reichardt LF and 
Taylor JM. Cardiac-restricted FAK inactivation attenuates pressure-overload 
induced hypertrophy. Circulation Research. 2006

Liu P, Patil S., Rojas M, Fong A., Smyth S.S., and Patel D.D. CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. ATVB. 2006; 26:2056-2062

Evangelista V, Pamuklar Z, Piccoli A, Manarini S, Dell'Elba G, Pecce R, Martelli N, Federico L, Rojas M, Berton G, Lowell CA, Totani L, and Smyth SS. Src family kinases mediate neutrophil adhesion to adherent platelets. Blood. 2007 Mar 15;109(6):2461-9.

Barrick C, Rojas M, Schoonhoven R, Smyth S, Threadgill DW. Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal and background dependent development of concentric left ventricular hypertrophy. Am J Physiology Heart Circ Physiol. 2006 Dec 15

Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2007 Apr14.

Niu XL, Li J, Hakim ZS, Rojas M, Runge MS, Madamanchi NR. Lar deficiency enhances IGF-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.  J Biol Chem. 2007 May 11

Stansfield WE & Rojas M (co-authors), Corn D, Willis M, Patterson C, Smyth SS, Selzman CH. Characterization of a Model to Independently Study Regression of Ventricular Hypertrophy. J Surg Res. 2007 Oct; 142(2): 387-93.

Vendrov AE, Hakim ZS, Madamanchi NR, Rojas M, Madamanchi C, and Runge MS. Atherosclerosis Is Attenuated by Limiting Superoxide Generation in Both Macrophages and Vessel Wall Cells. Arterioscler. Thromb. Vasc. Biol. 2007 Dec; 27(12): 2714-21.

Chen J, Murchison E, Tang R, Callis T, Tatsuguchi M, Deng Z, Rojas M, Hammond S, Schneider M, Selzman CH, Meissner G, Patterson C, Hannon G, Wang DZ. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA. 2008; 105: 2111-6.

Pandya K, Cowhig J, Brackhan J, Kim HS, Hagaman J, Rojas M, Carter Jr, Mao L, Rockman HA, Maeda N, Smithies O. Discordant on/off switching of gene expression in myocytes during cardiac hypertrophy in vivo.
Proc Natl Acad Sci U S A. 2008 Aug 28.

Sayers RL, Sundberg-Smith LJ, Rojas M, Hayasaka H, Parsons JT, Mack CP, Taylor RL. FRNK expression promotes smooth muscle cell maturation during vascular development and after vascular injury. Arterioscler Throm Vasc Bio. 2008 Sep 11, 18787183

Hakim ZS, DiMichele LA, Rojas M, Mack CP, Taylor JM. FAK regulates cardiomyocyte survival following ischemia/reperfusion. J Mol Cell Cardiol. 2009 Feb; 46(2): 241-8.

Dimichele LA, Hakim ZS, Sayers RL, Rojas M, Schwartz RJ, Mack CP, Taylor JM. Transient expression of FRNK reveals stage-specific requirement for focal adhesion kinase activity in cardiac growth. Circ Res. 2009, May 22; 104 (10): 1201-8

Barrack CJ, Roberts RB, Rojas M, Rajamannan NM, Suitt CB, O'Brien KD, Smyth SS, Threadgill DW. Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice. Am J Physiol Heart Circ Physiol. 2009 Jul; 297(1): 65-75

Willis MS, Rojas M, Li L, Selzman CH, Tang RH, Stansfield WE, Rodriguez JE, Glass DJ, Patterson C.
Muscle ring finger 1 mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol. 2009 Apr; 296(4): H997-H1006.

Stan field WE, Charles PC, Tang RH, Rojas M, Bhati R, Moss NC, Patterson C, Selzman CH. Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile. J Thorac Cardiovasc Surg. 2009 Jan; 137(1): 232-8, 238e1-8

Niu XL, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, Brandes RP, Krause KH, Humphries J, Smith A, Burnand KG, Range MS. Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation. 2010 Feb 2; 121(4): 549-59. Epub 2010, Jan 18.

Antoniak S, Rojas M, Spring D, Bullard T, Verrier E, Bacall B, Mackman N, Pawlinski R. Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury. Arterioscler Thrombi Vass Biol. 2010, Aug 19.

Jerath MR, Liu P, Struthers M, Demetrio JA, Peng R, Peterson LB, Cumiskey AM, Yang L, Rojas M, Patel DD, Fong AM. Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation. Thrombi J. 2010 Sep 13;8(1): 14

Gherghe CM, Duan J, Gong J, Rojas M, Klauber-Demore N, Majesky M, Deb A. Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF- dependent manner. FASEB J. 2011 Feb 14